- Home
- RVPHW vs MCHPP Comparison
RVPHW vs MCHPP Comparison
Compare RVPHW & MCHPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPHW
- MCHPP
- Stock Information
- Founded
- RVPHW 2018
- MCHPP N/A
- Country
- RVPHW United States
- MCHPP United States
- Employees
- RVPHW 14
- MCHPP 19400
- Industry
- RVPHW Biotechnology: Pharmaceutical Preparations
- MCHPP Semiconductors
- Sector
- RVPHW Health Care
- MCHPP Technology
- Exchange
- RVPHW Nasdaq
- MCHPP Nasdaq
- Market Cap
- RVPHW N/A
- MCHPP N/A
- IPO Year
- RVPHW N/A
- MCHPP N/A
- Fundamental
- Price
- RVPHW $0.04
- MCHPP $57.74
- Analyst Decision
- RVPHW
- MCHPP
- Analyst Count
- RVPHW 0
- MCHPP 0
- Target Price
- RVPHW N/A
- MCHPP N/A
- AVG Volume (30 Days)
- RVPHW 22.4K
- MCHPP N/A
- Earning Date
- RVPHW 03-14-2025
- MCHPP N/A
- Dividend Yield
- RVPHW N/A
- MCHPP N/A
- EPS Growth
- RVPHW N/A
- MCHPP N/A
- EPS
- RVPHW N/A
- MCHPP N/A
- Revenue
- RVPHW N/A
- MCHPP N/A
- Revenue This Year
- RVPHW N/A
- MCHPP N/A
- Revenue Next Year
- RVPHW N/A
- MCHPP N/A
- P/E Ratio
- RVPHW N/A
- MCHPP N/A
- Revenue Growth
- RVPHW N/A
- MCHPP N/A
- 52 Week Low
- RVPHW $0.13
- MCHPP N/A
- 52 Week High
- RVPHW $0.15
- MCHPP N/A
- Technical
- Relative Strength Index (RSI)
- RVPHW 43.57
- MCHPP N/A
- Support Level
- RVPHW $0.03
- MCHPP N/A
- Resistance Level
- RVPHW $0.05
- MCHPP N/A
- Average True Range (ATR)
- RVPHW 0.01
- MCHPP 0.00
- MACD
- RVPHW -0.00
- MCHPP 0.00
- Stochastic Oscillator
- RVPHW 17.86
- MCHPP 0.00
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About MCHPP Microchip Technology Incorporated
Microchip Technology became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.